These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25943561)

  • 1. A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.
    Chen W; Gao R; Xie X; Zheng Z; Li H; Li S; Dong F; Wang L
    Sci Rep; 2015 May; 5():9884. PubMed ID: 25943561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice.
    Manio MC; Inoue K; Fujitani M; Matsumura S; Fushiki T
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
    Zizola C; Kennel PJ; Akashi H; Ji R; Castillero E; George I; Homma S; Schulze PC
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1078-85. PubMed ID: 25713305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
    Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
    J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model.
    Li X; Li J; Lu X; Ma H; Shi H; Li H; Xie D; Dong L; Liang C
    Int J Mol Med; 2015 Sep; 36(3):767-75. PubMed ID: 26133486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARδ Promotes Running Endurance by Preserving Glucose.
    Fan W; Waizenegger W; Lin CS; Sorrentino V; He MX; Wall CE; Li H; Liddle C; Yu RT; Atkins AR; Auwerx J; Downes M; Evans RM
    Cell Metab; 2017 May; 25(5):1186-1193.e4. PubMed ID: 28467934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W; Wang LL; Liu HY; Long L; Li S
    Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice.
    Bernardo BL; Wachtmann TS; Cosgrove PG; Kuhn M; Opsahl AC; Judkins KM; Freeman TB; Hadcock JR; LeBrasseur NK
    PLoS One; 2010 Jun; 5(6):e11307. PubMed ID: 20593012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated linoleic acid (CLA) promotes endurance capacity via peroxisome proliferator-activated receptor δ-mediated mechanism in mice.
    Kim Y; Kim D; Park Y
    J Nutr Biochem; 2016 Dec; 38():125-133. PubMed ID: 27736732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent hyperbaric exposure on endurance and interval exercise performance in well-trained mice.
    Suzuki J
    Exp Physiol; 2019 Jan; 104(1):112-125. PubMed ID: 30457682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
    Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARδ agonist enhances colitis-associated colorectal cancer.
    Zhou D; Jin J; Liu Q; Shi J; Hou Y
    Eur J Pharmacol; 2019 Jan; 842():248-254. PubMed ID: 30391747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK and PPARdelta agonists are exercise mimetics.
    Narkar VA; Downes M; Yu RT; Embler E; Wang YX; Banayo E; Mihaylova MM; Nelson MC; Zou Y; Juguilon H; Kang H; Shaw RJ; Evans RM
    Cell; 2008 Aug; 134(3):405-15. PubMed ID: 18674809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
    Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
    Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.
    Mosti MP; Stunes AK; Ericsson M; Pullisaar H; Reseland JE; Shabestari M; Eriksen EF; Syversen U
    Endocrinology; 2014 Jun; 155(6):2178-89. PubMed ID: 24708238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor δ (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR).
    Pokrywka A; Cholbinski P; Kaliszewski P; Kowalczyk K; Konczak D; Zembron-Lacny A
    J Physiol Pharmacol; 2014 Aug; 65(4):469-76. PubMed ID: 25179079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition.
    Kino T; Rice KC; Chrousos GP
    Eur J Clin Invest; 2007 May; 37(5):425-33. PubMed ID: 17461989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
    Dimopoulos N; Watson M; Green C; Hundal HS
    FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
    Brunmair B; Staniek K; Dörig J; Szöcs Z; Stadlbauer K; Marian V; Gras F; Anderwald C; Nohl H; Waldhäusl W; Fürnsinn C
    Diabetologia; 2006 Nov; 49(11):2713-22. PubMed ID: 16960684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.